Have you heard about a relatively new diabetes medication for weight loss? Ozempic®, Wegovy®, and Rybelsus® are FDA-approved insulin management drugs whose side effects include weight loss of up to 30%. Semaglutide is the active ingredient in Ozempic®, Wegovy®, and Rybelsus® . Because these medications are on the the FDA shortage list and difficult to obtain, compounding pharmacies are able to prepare a compounded version of the drug. Our clinic prescribes compounded semaglutide. Our prices are significantly lower than brand name formulations. Our patients are achieving similar results with this alternative! Semaglutide for chronic weight management is a turning point in the treatment of obesity.